SrivandanaAkshintalaMDM.B.B.S

Pediatric Hematology & Oncology • Washington, DC

Clinical Fellow at Children's National Medical Center

Join to view full profile

Dr. Akshintala is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Akshintala's full profile

Already have an account?

Office
111 Michigan Ave Nw
Dept Of Hematology/Oncology
Washington, DC 20010
Phone+1 202-476-2800

Fax+1 202-476-5685

Education & Training

Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 2010 - 2013
SUNY Downstate Health Sciences UniversityResidency, Pediatrics, 2007 - 2010
Maulana Azad Medical CollegeClass of 2004

Certifications & Licensure

NY State Medical License 2015 - 2026
DC State Medical License 2010 - 2016
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2) Start of enrollment: 2018 Sep 24
Completed
Not Applicable

Publications & Presentations

PubMed

4 citations
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma.
Srivandana Akshintala, R Taylor Sundby, Donna Bernstein, John W Glod, Rosandra N Kaplan
Clinical Cancer Research. 2023-09-01
6 citations
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials.
Srivandana Akshintala, Nicole C Mallory, Yao Lu, Karla V Ballman, Scott M Schuetze
The Oncologist. 2023-05-08
Fracture Risk in Pediatric Patients With MEN2B.
Iris Li, Iris R Hartley, Joanna Klubo-Gwiedzdzinska, James C Reynolds, Barbara J Thomas
The Journal of Clinical Endocrinology and Metabolism. 2022-11-25

Lectures

Outcome of patients with refractory malignant peripheral nerve sheath tumors (MPNST) enrolled on phase 2 trials.
2019 ASCO Annual Meeting - 6/1/2019

Other Languages

Hindi, Telugu, Urdu